Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate

Por um escritor misterioso
Last updated 22 dezembro 2024
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Crystallographic data for p38 MAPK.a
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Full article: Structural based investigation of novel pyrazole
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
p38 MAP kinases: key signalling molecules as therapeutic targets
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Novel strategies for inhibition of the p38 MAPK pathway: Trends in
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
New modifications to the area of pyrazole-naphthyl urea based p38
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Frontiers Urea-based anticancer agents. Exploring 100-years of
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Structure-based design, synthesis and biological evaluation of N
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
Role of p38 MAP Kinase Signal Transduction in Solid Tumors - Hari
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to  Clinical Candidate
PDF) Clinical candidates of small molecule p38 MAPK inhibitors for

© 2014-2024 galemiami.com. All rights reserved.